Ads
related to: sphingolipids vs glycolipids 1 and 3 test
Search results
Results From The WOW.Com Content Network
The structural similarity of most glycolipids is the so-called lactosylceramide, that is, a lactose disaccharide that is glycosidically bound to a ceramide. Larger structures are subdivided into different groups by the sequence and configuration of the sugars, the four most common being globo-, lacto-, neoLacto- and gangliose.
The long-chain bases, sometimes simply known as sphingoid bases, are the first non-transient products of de novo sphingolipid synthesis in both yeast and mammals. These compounds, specifically known as phytosphingosine and dihydrosphingosine (also known as sphinganine, [4] although this term is less common), are mainly C 18 compounds, with somewhat lower levels of C 20 bases. [5]
Glycolipid. Glycolipids are lipids with a carbohydrate attached by a glycosidic (covalent) bond. [1] Their role is to maintain the stability of the cell membrane and to facilitate cellular recognition, which is crucial to the immune response and in the connections that allow cells to connect to one another to form tissues. [2]
Stage-specific embryonic antigen 3 (SSEA-3) is a glycosphingolipid, specifically, an oligosaccharide composed of five carbohydrate units connected to a sphingolipid, also known as globoside-5 (Gb5). Sphingolipids were originally discovered in 1884 by Johann Ludwig Wilhelm Thudichum who named them after the Sphinx of Greek mythology in reference ...
The heads of glycolipids (glyco- stands for sugar) contain a sphingosine with one or several sugar units attached to it. The hydrophobic chains belong either to: two fatty acids (FA) – in the case of the phosphoglycerides, or; one FA and the hydrocarbon tail of sphingosine – in the case of sphingomyelin and the glycolipids.
The primary saponifiable lipids are free fatty acids, neutral glycerolipids, glycerophospholipids, sphingolipids, and glycolipids. [ 1 ] By comparison, the non-saponifiable class of lipids is made up of terpenes, including fat-soluble A and E vitamins, and certain steroids, such as cholesterol.
[1] [2] In humans, SPH represents ~85% of all sphingolipids, and typically makes up 10–20 mol % of plasma membrane lipids. Sphingomyelin was first isolated by German chemist Johann L.W. Thudicum in the 1880s. [3] The structure of sphingomyelin was first reported in 1927 as N-acyl-sphingosine-1-phosphorylcholine. [3]
Taken together, sphingolipidoses have an incidence of approximately 1 in 10,000, but substantially more in certain populations such as Ashkenazi Jews. Enzyme replacement therapy is available to treat mainly Fabry disease and Gaucher disease, and people with these types of sphingolipidoses may live well into adulthood.